Related Experiment Video
Updated: May 14, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Cytomegalovirus infection and coronary artery disease in liver transplant recipients: Nationwide study using
Moises Alberto Suarez-Zdunek1, Ask Bock1, Nicolai Aagaard Schultz2
1Department of Infectious Diseases, Viroimmunology Research Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Insights
Cytomegalovirus (CMV) infection does not appear to increase the risk of coronary artery disease (CAD) in liver transplant recipients. This study found no association between prior CMV infection and the presence or severity of CAD post-transplant.
Area of Science:
- Cardiology
- Transplantation Immunology
- Infectious Diseases
Background:
- Liver transplant recipients face a high burden of coronary artery disease (CAD).
- Post-transplant cytomegalovirus (CMV) infection is common and linked to inflammation, potentially accelerating atherosclerosis.
- The relationship between CMV infection and CAD in this population requires further investigation.
Purpose of the Study:
- To investigate the association between cytomegalovirus (CMV) infection and coronary artery disease (CAD) in liver transplant recipients.
Main Methods:
- The Danish Comorbidity in Liver Transplant Recipients (DACOLT) study enrolled adult liver transplant recipients.
- Participants underwent cardiac computed tomography for CAD assessment and CMV DNAemia screening.
- The study assessed associations between prior CMV DNAemia, pre-transplant CMV serostatus, and CAD.
Main Results:
- Out of 278 recipients, 44% had calcified plaque (coronary artery calcium score [CACS] ≥1) and 29% had prior CMV DNAemia.
- No significant differences in CACS or CAD severity were observed between those with and without prior CMV DNAemia.
- Prior CMV DNAemia and positive CMV serostatus were not associated with any calcified plaque or CAD measures after adjustments.
Conclusions:
- No association was found between prior CMV infection and CAD in liver transplant recipients.
- CMV infection appears to play a limited role in the development of CAD after liver transplantation.
Objectives:
Liver transplant recipients have a high burden of coronary artery disease (CAD). Post-transplant cytomegalovirus (CMV) infection is common and is associated with inflammation, possibly promoting atherosclerosis. We investigated if CMV infection is associated with CAD in liver transplant recipients.
Methods:
In the Danish Comorbidity in Liver Transplant Recipients (DACOLT) Study (ClinicalTrials.gov: NCT04777032), adult liver transplant recipients underwent research cardiac computed tomography with assessment of CAD and systematic screening for CMV DNAemia. We assessed if prior CMV DNAemia and pre-transplant CMV serostatus were associated with CAD.
Results:
We included 278 liver transplant recipients, of whom 44% had any calcified plaque (coronary artery calcium score [CACS] ≥1), and 29% had prior CMV DNAemia. The distribution of CACS (P = 0.514) and CAD severity (P = 0.198) did not differ between participants with and without prior CMV DNAemia. Prior CMV DNAemia and positive CMV serostatus were not associated with any calcified plaque (aOR: 0.72 [95% CI: 0.36-1.46] and 1.04 [0.55-1.98], respectively) or any measures of CAD after adjustment for traditional cardiovascular risk factors and time since transplantation.
Conclusions:
We found no association between prior CMV infection and CAD in liver transplant recipients, indicating a limited role on postliver transplantation CAD.
Related Concept Videos
Cytomegalovirus Disease
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
